Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling

N. Fens, A. G. J. van Rossum, P. Zanen, B. van Ginneken, R. J. van Klaveren, A. H. Zwinderman, P. J. Sterk (Amsterdam, Utrecht, Rotterdam, Netherlands)

Source: Annual Congress 2010 - COPD: diagnosis
Session: COPD: diagnosis
Session type: Thematic Poster Session
Number: 4020
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Fens, A. G. J. van Rossum, P. Zanen, B. van Ginneken, R. J. van Klaveren, A. H. Zwinderman, P. J. Sterk (Amsterdam, Utrecht, Rotterdam, Netherlands). Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling. Eur Respir J 2010; 36: Suppl. 54, 4020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identification of asthma phenotypes using cluster analysis
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018

Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011



Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype
Source: Virtual Congress 2021 – Environment and air pollution
Year: 2021

External validation of exhaled breath molecular profiling in identifying COPD and asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010


Exhaled breath molecular profiling in measuring inflammatory status in COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008


Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017

Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath
Source: ERS Lung Science Conference 2016
Year: 2016




Real-time exhaled breath analysis identifies altered metabolic signature in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017


Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

Use of cluster analysis to define COPD phenotypes
Source: Eur Respir J 2010; 36: 472-474
Year: 2010


Exclusion of asthma for screening purposes using exhaled air molecular profiling by electronic nose
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011

Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006

Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Identification of COPD phenotypes using factor analysis
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009


COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019